<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-molecules-26-00438">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Calvo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gimenez</surname>
    <given-names>M.-J.</given-names>
   </name>
   <name>
    <surname>Alou</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>GÃ³mez-Lus</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Aguilar</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Prieto</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae</article-title>
  <source>Int. J. Antimicrob. Agents</source>
  <year>2002</year>
  <volume>20</volume>
  <fpage>144</fpage>
  <lpage>146</lpage>
  <pub-id pub-id-type="doi">10.1016/S0924-8579(02)00119-X</pub-id>
  <pub-id pub-id-type="pmid">12297365</pub-id>
 </element-citation>
</ref>
